Wave of Ozempic Lawsuits Emerges, Poised to Rock the Realm of Mass Litigation
COLUMBUS, Ohio – As the pharmaceutical industry faces a wave of lawsuits, some legal experts are speculating if the next major litigation battle will revolve around the diabetes medication, Ozempic. The drug, manufactured by Danish pharmaceutical company Novo Nordisk, has recently gained popularity for its effectiveness in reducing blood sugar levels and promoting weight loss. However, several lawsuits have been filed alleging that the drug causes serious side effects, including pancreatitis and pancreatic cancer. Despite the drug’s potential risks, Novo Nordisk continues to defend the safety and efficacy of Ozempic. Ozempic belongs to a class … Read more